Literature DB >> 22715548

Pioglitazone safe, so save.

Samar Banerjee1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715548

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


× No keyword cloud information.
  5 in total

1.  Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review.

Authors:  Saarwaani Vallabhajosyula; Shashaank Vallabhajosyula; Saraschandra Vallabhajosyula; Suma Nair; Asha Kamath; Karthik N Rao
Journal:  Med J Armed Forces India       Date:  2016-08-09

2.  Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.

Authors:  Sunil Gupta; Kavita Gupta; R Ravi; Vinita Mehta; Samar Banerjee; Shashank Joshi; Banshi Saboo
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

3.  Rubia tinctorum root extracts: chemical profile and management of type II diabetes mellitus.

Authors:  Enas E Eltamany; Mohamed S Nafie; Dina M Khodeer; Aya H H El-Tanahy; Maged S Abdel-Kader; Jihan M Badr; Reda F A Abdelhameed
Journal:  RSC Adv       Date:  2020-06-24       Impact factor: 4.036

4.  Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.

Authors:  Elena Pavlova Filipova; Katya Hristova Uzunova; Toni Yonkov Vekov
Journal:  Diabetol Metab Syndr       Date:  2015-07-16       Impact factor: 3.320

Review 5.  Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis.

Authors:  Elena Filipova; Katya Uzunova; Krassimir Kalinov; Toni Vekov
Journal:  Diabetol Metab Syndr       Date:  2017-11-14       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.